mTOR activity can oversee insulin signaling in experimental models of AD and maintain astrocyte viability [321], prevent endothelial cell dysfunction during periods of hyperglycemia [322], and maintain glucose homeostasis [261]. This evidence concerns the gene MTOR and Alzheimer disease.